Phase II Trial of TAS-102 in Colorectal Cancer Patients With Circulating Tumor DNA-Defined Minimal Residual Disease After Adjuvant Therapy: INTERCEPT-TT A multiplex QIF assay was optimized on tissue ...
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the placement of the 1 ...
Duke University scientists have discovered that pancreatic alpha cells, long believed to only produce glucagon, actually ...
HTRF uses two fluorophores, a donor and an acceptor, to label proteins or other targeted biomolecules. When these ...
Making blood in the lab can be hard because scientists don’t know what triggers a key final step in red blood cell maturation ...
A new study from Duke University School of Medicine is challenging long-standing views on blood sugar regulation—and pointing ...
The global research antibodies and reagents market is projected to grow at a CAGR of 7% from 2025 to 2030, driven by ...
From axolotls to zebrafish, stem cells possess remarkable regenerative abilities, enabling them to restore lost limbs and repair damaged organs. These extraordinary capabilities, however, are not ...
A new study from Duke University School of Medicine is challenging long-standing views on blood sugar regulation — and pointing to a surprising new ally in the fight against type 2 diabetes.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback